GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Statera BioPharma Inc (STU:7CB) » Definitions » Pre-Tax Income

Statera BioPharma (STU:7CB) Pre-Tax Income : €-82.11 Mil (TTM As of Sep. 2022)


View and export this data going back to 2021. Start your Free Trial

What is Statera BioPharma Pre-Tax Income?

Pretax income is the income that a company earns before paying income taxes. Statera BioPharma's pretax income for the three months ended in Sep. 2022 was €-3.39 Mil. Its pretax income for the trailing twelve months (TTM) ended in Sep. 2022 was €-82.11 Mil. Statera BioPharma's pretax margin was %.


Statera BioPharma Pre-Tax Income Historical Data

The historical data trend for Statera BioPharma's Pre-Tax Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Statera BioPharma Pre-Tax Income Chart

Statera BioPharma Annual Data
Trend Dec19 Dec20 Dec21
Pre-Tax Income
-2.90 -10.37 -90.16

Statera BioPharma Quarterly Data
Dec19 Mar20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22
Pre-Tax Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only -10.82 -68.37 -7.05 -3.30 -3.39

Competitive Comparison of Statera BioPharma's Pre-Tax Income

For the Biotechnology subindustry, Statera BioPharma's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Statera BioPharma's Pre-Tax Income Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Statera BioPharma's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where Statera BioPharma's Pre-Tax Income falls into.



Statera BioPharma Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

Statera BioPharma's Pretax Income for the fiscal year that ended in Dec. 2021 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=-25.946+-60.177+-4.036+0+-1.4210854715202E-14
=-90.16

Statera BioPharma's Pretax Income for the quarter that ended in Sep. 2022 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=-1.482+-0.08+-1.828+0+-0.00099999999999989
=-3.39

Pre-Tax Income for the trailing twelve months (TTM) ended in Sep. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was €-82.11 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Statera BioPharma  (STU:7CB) Pre-Tax Income Explanation

Statera BioPharma's Pretax Margin for the quarter that ended in Sep. 2022 is calculated as

Pretax Margin=Pretax Income/Revenue
=-3.391/0
=%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Statera BioPharma Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of Statera BioPharma's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.


Statera BioPharma (STU:7CB) Business Description

Traded in Other Exchanges
N/A
Address
4333 Corbett Drive, Suite 1082, Fort Collins, CO, USA, 80525
Statera BioPharma Inc is a pre-clinical and clinical biopharmaceutical company developing multiple product candidates to address unmet medical needs for use in diseases involving immune system dysfunction.

Statera BioPharma (STU:7CB) Headlines

No Headlines